Specialty pharmacies and other restricted drug distribution systems: Financial and safety considerations for patients and health-system pharmacists

American Journal of Health-System Pharmacy

Volumn 66, Issue SUPPL. 7, 2009, Pages

  Kirschenbaum, Bonnie E ^a  

^a NONE   (United States)

Author keywords

Costs; Drug distribution systems; Economics; Food and Drug Administration (U.S.); Health benefit programs; Pharmacists, hospital; Pharmacy; Pharmacy, institutional, hospital; Regulations; Reimbursement; Risk management Specialties; Toxicity

Indexed keywords

CONFERENCE PAPER; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG PACKAGING; DRUG SAFETY; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; MEDICARE; PATIENT CARE; PHARMACIST; PHARMACY; PRIORITY JOURNAL; REIMBURSEMENT; RISK ASSESSMENT; RISK EVALUATION AND MITIGATION STRATEGY; RISK MANAGEMENT;

EID: 74049095952     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp090462     Document Type: Conference Paper

References (16)

1. 110th U.S. Congress. Food and Drug Administration Amendments Act of 2007. http://frwebgate.access.gpo.gov/ cgi-bin/getdoc.cgi?dbname=110-cong- public-laws&docid=f:publ085.110 (accessed 2009 Jun 11).
2. U.S. Food and Drug Administration. Sec. 505-1. [21 USC §355-1] Risk evaluation and mitigation strategies. http://www. fda.gov/RegulatoryInformation/ Legislation/FederalFoodDrugand CosmeticActFDCAct/FDCActChapter VDrugsandDevices/ucm109090.htm (accessed 2009 Jun 11).
3. Armitstead J, Loyd L, Pane F et al. Implications of the specialty drug marketplace for health-system pharmacy: a roundtable discussion. Am J Health-Syst Pharm. 2007; 64:2364-72.
4. Specialty Pharmacy Network. What is specialty pharmacy. http://www.specialty pharmacy.com/ (accessed 2009 Jun 11).
5. Prescription Solutions. Specialty pharmacy. https://www. prescriptionsolutions. com/RxsolHcpWeb/specialty-pharma/ index.html (accessed 2009 Jun 11).
6. U.S. Food and Drug Administration. Approved risk evaluation and mitigation strategies (REMS). http://www.fda. gov/Drugs/DrugSafety/ PostmarketDrug SafetyInformationforPatientsand Providers/ucm111350.htm (accessed 2009 Jun 11).
7. Flolan package insert. Research Triangle Park, NC: GlaxoSmithKline; 2008 Jan.
8. Johnson PE. Pharmaceutical reimbursement: an overview. Am J Health-Syst Pharm. 2008; 65(2 Suppl 1):S4-10.
9. Centers for Medicare & Medicaid Services. Information partners can use on: Medicare drug coverage under Medicare Part A, Part B, and Part D. Revised May 2009. http://www.cms.hhs.gov/ partnerships/downloads/11315-P.pdf (accessed 2009 Jun 23).
10. Centers for Medicare & Medicaid Services. Hospital outpatient prospective payment system, http://www.cms. hhs.gov/MLNProducts/downloads/ HospitalOutpaysysfctsht.pdf (accessed 2009 Jun 20).
11. Rogers C. New Rx co-pay tier hurts ill: some plans push costs of pricey drugs on patients. Detroit News. 2008; Jul 14.
12. Sullivan SD. The promise of specialty pharmaceuticals: are they worth the price? J Manag Care Pharm. 2008; 14(4 Suppl):S3-6.
13. CuraScript Pharmacy Inc. 2004 specialty pharmacy management guide & trend report. June 2005. http://www. express-scripts.com/industryresearch/ industryreports/specialtytrendreport/ 2004/strFinal.pdf (accessed 2009 Jun 23).
14. Next-generation specialty pharmacy management strategies for health plans. July 9, 2008. http://www.aishealth.com/ Products/C8P16-070908. html(accessed 2009 Jun 22).
15. Learner N. Biotech, pharma firms eye new payment models based on value. July 24, 2008. http://www.aishealth. com/DrugCosts/DBN-Biotech-Pharma- Payment.html (accessed 2009 Jun 11).
16. Brower A. Infusion centers for specialty drugs: hospitals step up. http://drug topics.modernmedicine.com/ drugtopicsModern+Medicine+Now/ Infusion-centers-for-specialty-drugs-Hospitals-ste/ArticleStandard/ Article/ detail/596064 (accessed 2009 Jun 11).